A. Joseph Tector
ORCID: 0000-0002-9865-8382Also affiliated with Io Therapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “Anti-C5 Antibody Tesidolumab Reduces Early Antibody-mediated Rejection and Prolongs Survival in Renal Xenotransplantation”.
Brendan P. Lovasik, David A. Faber, Christopher Burlak, Cynthia Breeden, José L. Estrada +5 more
Andrew Adams, Matt Tector, A. Joseph Tector
Luz M. Reyes, Jose R. Estrada, Christopher Burlak, Victor Novara Gennuso, Mosely O. Tector +4 more
Zheng‐Yu Wang, Jose R. Estrada, Christopher Burlak, Victor Novara Gennuso, Sam Ho +3 more
Matt Tector, G. Martens, Zheng‐Yu Wang, C. Burlak, Luz M. Reyes +4 more
Abraham J. Matar, Jakob Habib, David A. Faber, Cynthia Breeden, Alton B. Farris +3 more
Luz M. Reyes, Zhang Yu Wang, C. Burlak, Victor Novara Gennuso, Ovidio Figueroa +6 more
Matt Tector, Sabrina Copsel, Zhang Yu Wang, C. Burlak, Luz M. Reyes +4 more